Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

Blood (2022) 140 (18): 1997–2000.

https://doi.org/10.1182/blood.2022017616

Published: 2022

Includes: Supplemental data

Journal Articles

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Anita D'Souza, Martha Lacy, Morie Gertz, Shaji Kumar, Francis Buadi, Suzanne Hayman, David Dingli, Steven Zeldenrust, Robert Kyle, Stephen Ansell, David Inwards, Patrick Johnston, Ivana Micallef, Luis Porrata, Mark Litzow, Dennis Gastineau, William Hogan, Angela Dispenzieri

Blood (2012) 120 (1): 56–62.

https://doi.org/10.1182/blood-2012-04-423178

Published: 2012

Journal Articles

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Shirshendu Sinha, MBBS, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Kristen Detweiler Short, RN, CNP, Joseph Mikhael, MD, Angela Dispenzieri, MD, Morie Gertz, MD, David Dingli, M.D., Ph.D., S. Vincent Rajkumar, MD, Martha Lacy, MD

Blood (2010) 116 (21): 1965.

https://doi.org/10.1182/blood.V116.21.1965.1965

Published: 2010

Journal Articles

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

Shirshendu Sinha, MBBS, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, MD, Ph.D., Ivana Micallef, MD, William Hogan, MBBCh, Dennis Gastineau, MD, S. Vincent Rajkumar, MD, Shaji Kumar, MD

Blood (2010) 116 (21): 2253.

https://doi.org/10.1182/blood.V116.21.2253.2253

Published: 2010

Journal Articles

At-101 Induces Apoptosis Waldenström Macroglobulinemia Cells Resistant to Bortezomib.

Kasyapa Chitta, Ph.D., Kiersten M. Miles, Pushpankur Ghoshal, PhD, Leighton Stein, Morton Coleman, MD, Richard R Furman, MD, Hofmeister Craig, MD, Suzanne Hayman, Kelvin P. Lee, MD, Asher Alban Chanan-Khan

Blood (2009) 114 (22): 2861.

https://doi.org/10.1182/blood.V114.22.2861.2861

Published: 2009

Journal Articles

Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma.

Blood (2009) 114 (22): 3884.

https://doi.org/10.1182/blood.V114.22.3884.3884

Published: 2009

Journal Articles

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Francis Buadi, MD, Martha Q. Lacy, MD, Angela Dispenzieri, M.D., Shaji Kumar, Suzanne Hayman, MD, Kristen E Detweiler Short, R.N., C.N.P., David Dingli, M.D., PhD., Steven R. Zeldenrust, M.D., Ph.D., Philip R. Greipp, MD, John A. Lust, MD, PhD, Stephen J. Russell, MD, PhD, Robert Kyle, M.D., Vincent Rajkumar, MD, Morie A Gertz, MD

Blood (2009) 114 (22): 4953.

https://doi.org/10.1182/blood.V114.22.4953.4953

Published: 2009

Journal Articles

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Kasyapa Chitta, Ph.D., Jean-Gabriel Coignet, Sakina Sojar, Pushpankur Ghoshal, PhD, Kiersten M. Miles, Leighton Stein, Morton Coleman, MD, Richard R. Furman, MD, Craig Hofmeister, MD, Suzanne Hayman, MD, Kelvin P. Lee, MD, Asher A. Chanan-Khan, MD

Blood (2009) 114 (22): 4919.

https://doi.org/10.1182/blood.V114.22.4919.4919

Published: 2009

Journal Articles

Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients.

Bharathi Aravamudan, Ph.D., Caili Tong, Martha Q. Lacy, MD, Suzanne Hayman, MD, Francis Buadi, MD, Morie A Gertz, MD, Shaji Kumar, Stephen J. Russell, MD, PhD, Angela Dispenzieri, MD

Blood (2009) 114 (22): 4986.

https://doi.org/10.1182/blood.V114.22.4986.4986

Published: 2009

Journal Articles

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Sumit Madan, M.D., Shaji Kumar, M.D., Angela Dispenzieri, MD, Martha Q. Lacy, MD, Suzanne Hayman, MD, Francis Buadi, MD, David Dingli, M.D., PhD., Morie A Gertz, MD

Blood (2009) 114 (22): 534.

https://doi.org/10.1182/blood.V114.22.534.534

Published: 2009

Journal Articles

Phase II Trial of Lenalidomide (Revlimid ™ ) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma

Blood (2008) 112 (11): 91.

https://doi.org/10.1182/blood.V112.11.91.91

Published: 2008

Journal Articles

Post Autologous Transplantation Consolidation of Multiple Myeloma with Idiotype-Pulsed Antigen Presenting (Dendritic) Cells (APC8020) Is Associated with Prolonged Survival.

Martha Q. Lacy, MD, Sumithra Mandrekar, Brian Kabat, Angela Dispenzieri, Suzanne Hayman, Shaji Kumar, Francis Buadi, David Dingli, Mark Litzow, Peter Wettstein, S. Vincent Rajkumar, Dennis Gastineau, Morie A. Gertz, MD

Blood (2008) 112 (11): 1739.

https://doi.org/10.1182/blood.V112.11.1739.1739

Published: 2008

Journal Articles

Comparison of High-Dose Cyclophosphamide and Growth Factor with Growth Factor Alone for Mobilization of Stem Cells for Transplantation in Patients with Multiple Myeloma.

Morie Abraham Gertz, MD, Shaji Kumar, Martha Lacy, Angela Dispenzieri, Suzanne Hayman, Francis Buadi, David Dingli, Dennis Gastineau, Jeffery Winters, Mark Litzow

Blood (2008) 112 (11): 2301.

https://doi.org/10.1182/blood.V112.11.2301.2301

Published: 2008

Journal Articles

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

Lijo Simpson, MBBS, Morie Gertz, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis Buadi, MD, Vincent S. Rajkumar, MBBS, Shaji Kumar

Blood (2007) 110 (11): 3607.

https://doi.org/10.1182/blood.V110.11.3607.3607

Published: 2007

Journal Articles

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

Alan H. Bryce, MD, Rhett Ketterling, MD, Morie Gertz, MD, Steve Zeldenrust, MD, Martha Lacy, MD, Shaji Kumar, MD, Suzanne Hayman, MD, Francis Buadi, MD, Phillip Greipp, MD, John Lust, MD, Vincent Rajkumar, MD, Rafael Fonseca, MD, David Dingli, MD, Stephen Russell, MD, Robert Kyle, MD, Angela Dispenzieri, MD

Blood (2007) 110 (11): 2477.

https://doi.org/10.1182/blood.V110.11.2477.2477

Published: 2007

Journal Articles

Myeloma International Staging System Retains Its Prognostic Value at Disease Relapse.

Rajanshu Verma, MD, Shaji Kumar, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Philip R. Greipp, MD, S. Vincent Rajkumar, MD, Morie A. Gertz, MD

Blood (2007) 110 (11): 1474.

https://doi.org/10.1182/blood.V110.11.1474.1474

Published: 2007

Journal Articles

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Grzegorz S. Nowakowski, MD, Chin-Yang Li, MD, David Dingli, MD, PhD, Shaji Kumar, MD, Morie A. Gertz, MD, Martha Q. Lacy, MD, John A. Last, MD, Angela Dispenzieri, MD, Philip R. Greipp, MD, Steven Zeldenrust, MD, PhD, Francis Buadi, MD, Suzanne Hayman, MD, Robert A. Kyle, MD, Vincent S. Rajkumar, MD

Blood (2007) 110 (11): 1492.

https://doi.org/10.1182/blood.V110.11.1492.1492

Published: 2007

Journal Articles

Prognostic Value of Serum Lactate Dehydrogenase (LDH) in Patients with Primary Systemic Amyloidosis Undergoing Stem Cell Transplantation.

Shaji Kumar, MD, Martha Q. Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Francis K. Buadi, MD, David Dingli, MD, Mark R. Litzow, MD, Morie A. Gertz, MD

Blood (2007) 110 (11): 2871.

https://doi.org/10.1182/blood.V110.11.2871.2871

Published: 2007

Journal Articles

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Suzanne Hayman, MD, Morie Gertz, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Rafael Fonseca, MD, Susan Geyer, PhD, Shaji Kumar, MD, Steven Zeldenrust, MD, Stephen Russell, MD, PhD, John Lust, MD, PhD, Robert Kyle, MD, Philip Greipp, MD, Thomas Witzig, MD, S. Vincent Rajkumar, MD

Blood (2006) 108 (11): 3568.

https://doi.org/10.1182/blood.V108.11.3568.3568

Published: 2006

Journal Articles

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Shaji Kumar, MD, Martha Lacy, MD, Angela Dispenzieri, MD, Suzanne Hayman, MD, Nelson Leung, MD, Vincent Rajkumar, MD, Steven Zeldenrust, MD, John Lust, MD, Philip Greipp, MD, Dennis Gastineau, MD, Morie Gertz, MD

Blood (2006) 108 (11): 3091.

https://doi.org/10.1182/blood.V108.11.3091.3091

Published: 2006

NARROW

Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance

Long-term outcomes after autologous stem cell transplantation for patients with POEMS syndrome (osteosclerotic myeloma): a single-center experience

Response to Salvage Therapies and Outcome of Patients with Multiple Myeloma Relapsing After Pomalidomide Therapy

Peripheral Blood Stem Cell Collection In Patients Undergoing Induction Therapy with Lenalidomide Based Regimens: Failure Rates and Salvage Approaches

At-101 Induces Apoptosis Waldenström Macroglobulinemia Cells Resistant to Bortezomib.

Superiority of Lenalidomide-Dexamethasone Versus Thalidomide-Dexamethasone as Initial Therapy for Newly Diagnosed Multiple Myeloma.

Retrospective Study of the Efficacy of Bortezomib in Primary Systemic Amyloidosis.

Induced Resistance to Bortezomib in Preclinical Model of Waldenstrom Macroglobulinemia Is Associated with Bcl-2 Upregulation.

Analysis of the Immunoglobulin Heavy and Light Chain Gene Expression and Mutations in POEMS Patients.

Outcomes with High Dose Therapy and Peripheral Blood Stem Cell Transplantation for Light Chain (AL) Amyloidosis with Cardiac Involvement.

Phase II Trial of Lenalidomide (Revlimid ™ ) with Cyclophosphamide and Dexamethasone (RCd) for Newly Diagnosed Myeloma

Post Autologous Transplantation Consolidation of Multiple Myeloma with Idiotype-Pulsed Antigen Presenting (Dendritic) Cells (APC8020) Is Associated with Prolonged Survival.

Comparison of High-Dose Cyclophosphamide and Growth Factor with Growth Factor Alone for Mobilization of Stem Cells for Transplantation in Patients with Multiple Myeloma.

Thalidomide Based Induction Chemotherapy Prior to Stem Cell Transplantation in Myeloma Is Associated with Decreased Response to Retreatment with Thalidomide at First Relapse Post Transplant.

14q32 Abnormalities and 13q Deletions Are Common in Primary Systemic Amyloidosis Using Cytoplasmic Immunoglobulin Fluorescence In Situ Hybridization (cIg-FISH).

Myeloma International Staging System Retains Its Prognostic Value at Disease Relapse.

Increased Cytotoxic T-Cell Infiltrates in the Bone Marrow Is an Independent Adverse Prognostic Factor in Patients with Newly Diagnosed Multiple Myeloma.

Prognostic Value of Serum Lactate Dehydrogenase (LDH) in Patients with Primary Systemic Amyloidosis Undergoing Stem Cell Transplantation.

Long-Term Results of Single-Agent Thalidomide as Initial Therapy for Asymptomatic (Smoldering or Indolent) Myeloma.

Autologous Stem Cell Transplantation for Multiple Myeloma in Patients with Reduced Renal Function: A Matched Set Comparison.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only